Ann: Appendix 4E Preliminary Final Report, page-2

according to their prospectus

Osteopore currently generates revenue in Singapore (6%), Malaysia (2%), South Korea (52%), Vietnam (33%) and in other nations (7%)
They focused on China market late 2019.

Given the virus scare, quarantine, and market stress, SP will probably go lower. 52% of the business is south korea which is badly affected by the virus scare. Even home base Singapore is in code orange. I don't think we've bottomed out yet. Eyeing on a better entry point... I like the business idea. looks like a good spec stock